IBA Annual Conference Copenhagen 2026
4 Oct - 9 Oct 2026
B3 3+4, Level 0
Session information
Compounding medicines and counterfeit prevention
Thursday 8 October (1115 - 1230)
B3 3+4, Level 0
Committee(s)
Healthcare and Life Sciences Law Committee
(Lead)
Criminal Law Committee
Description
Ensuring safety and quality in compounded pharmaceuticals, addressing industry challenges, and discussing measures to combat counterfeit drugs.
Session / Workshop Chair(s)
| Yurika Inoue | MORI HAMADA & MATSUMOTO, Tokyo, Japan; Asia Pacific Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee |
Speakers
| Julie Dohm | Covington and Burling, DC, Washington, USA |
| Raquel Frisardi | Novo Nordisk A/S, Bagsværd, Denmark |
| Ruta Karpiciute | Ellex Valiunas, Tallinn, Estonia |
| Koen T'Syen | Van Bael & Bellis, Brussels, Belgium |